Approval · Notice of Compliance 28603 · 2022
IPG-MODAFINIL: Notice of Compliance 28603
Issued July 14, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28603
- Date
- July 14, 2022
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph and Labelling
- Canadian reference product
- ALERTEC (Shire Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPG-MODAFINIL | Not yet assigned | — |
Medicinal ingredients
- MODAFINIL 100 MG per TAB